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A novel imaging and tissue analysis scheme in the terahertz frequency
band has the benefits of simplicity, coherence, and high sensitivity.
Terahertz radiation has an inherently low penetration depth in
hydrated biological tissue, so skin is an ideal target for imaging
at terahertz frequencies. Examining structures within the surface
layers of skin is a mainstay of diagnosis in pathology, and using
several different frequency regions to image these can provide
complementary information about skin structure and function.
The research community has successfully developed diagnostic
methods based on the response of tissue in the terahertz spec-
tral region.1 However, to date, the absence of a compact, robust,
inexpensive sensing solution has impeded general adoption of
terahertz radiation for biological applications.
The quantum cascade laser (QCL) is one of the most promis-
ing radiation sources for imaging at terahertz frequencies. As
with other lasers, QCLs exhibit self-mixing (SM), whereby
re-injection of emitted radiation into the laser cavity affects the
laser operating parameters. We can exploit this phenomenon for
sensing purposes, using it to measure displacement, velocity,
and fluid flow, as well as for coherent and incoherent imaging.
Here we present an imaging and tissue analysis scheme in the
terahertz band that exploits the interferometric nature of coher-
ent optical feedback in a terahertz QCL. SM interferometry is
essentially a homodyne detection scheme, where the stable local
oscillator signal (the QCL emission) is combined with the time-
delayed version of itself. Figure 1 shows the basic structure and
operating principles of our SM interferometer. The re-injected
light interferes (‘mixes’) with the intra-cavity electric field,
causing small variations in the fundamental laser parameters,
Figure 1. Schematic diagram of the setup for tissue imaging experi-
ments. PC DAQ: Data acquisition. Mod i/p: Modulation input. QCL:
Quantum cascade laser.
including the threshold gain, emitted power, lasing spectrum,
and laser terminal voltage.2 While optical feedback affects al-
most all laser parameters, the two we can most conveniently
monitor are the emitted optical power and the voltage across
the laser terminals. Of these, monitoring the laser terminal volt-
age is preferable as it obviates the need for an external terahertz
detector.3 The small voltage variation (referred to as the SM sig-
nal) depends on both the amplitude and phase of the electric
field of the reflected laser beam. This results in a highly sensitive
and compact sensing technique that can probe information
about the complex reflectivity or refractive index of the external
target.
We can create SM signals by exploiting temporal variations
in optical length of the external cavity (through variation of its
refractive index or the physical length), complex reflectivity of
the target, or the laser frequency. The imaging process involves
illuminating static objects with terahertz radiation. In other
words, the objects being imaged are not changing during the
signal acquisition. Therefore, we require some type of modula-
tion to generate an SM signal. Here we opt for slow frequency
modulation,4 which results in an SM waveform imprinted with
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the complex refractive index of the target. The sensitivity of this
scheme is discussed in detail elsewhere.5
We performed tissue imaging experiments using porcine
tissue and murine skin. We first acquired a 2D array of time-
domain waveforms and then reduced each waveform to a
corresponding array of numbers, forming an image. Figure 2
shows results of the reflection-mode imaging of a 3mm-
diameter skin biopsy from the transgenic laboratory mouse
strain Cdk4::Tyr-NRAS.6, 7 The sample in Figure 2(a) shows a
barely visible stage 1 melanoma lesion on the left hand side of
the sample. Figure 2(b) shows a signal strength reduction of the
terahertz waveforms, while Figure 2(c) shows a corresponding
phase reduction from the array of SM waveforms. We can relate
the tumor plaque in this sample to features observable in the pair
of terahertz image reductions.
In summary, we developed a highly sensitive and compact
scheme that shows promise for biological imaging in the tera-
hertz frequency range. Our approach offers the possibility of
early detection of skin changes before they become apparent in
visible images. Our results also point toward techniques for the
characterization of healthy tissue types for the study of normal
physiology and possible therapeutic approaches. Additionally,
imaging of skin malignancy in animal models at terahertz
Figure 2. (a) Photograph of the 3mm diameter skin biopsy from
the Cdk4::Tyr-NRAS sample. (b) Trimmed total variation, showing a
signal strength reduction of the terahertz self-mixing waveforms.
(c) Trimmed last peak position, showing a phase-like reduction of the
terahertz self-mixing waveforms.
wavelengths shows earlier and potentially more powerful
discrimination than is currently possible in the visible and IR
regions of the spectrum.
Continuous improvements in terahertz QCL technology will
lead to devices operating at higher temperatures and conse-
quently more robust and compact self-mixing instruments for
tissue characterization. In future work, we will investigate the
origin of contrast in biological tissues based on water content
and distribution, and we will assess the innate molecular
response at terahertz frequencies. A clearer understanding of
these factors will guide us towards discriminating a variety
of skin pathologies.
This research was supported under the Australian Research Council’s
Discovery Projects funding scheme (DP 120 103703) and a Cancer
Research UK Leeds Centre Development Fund Equipment award
(Grant number C37059/A16369). We also acknowledge support of the
ERC ‘NOTES’ and ‘TOSCA’ programs, the Royal Society, theWolfson
Foundation, and the European Cooperation in Science and Technology
(COST) Action BM1205. Author Yah Leng Lim acknowledges support
under the Queensland Government’s Smart Futures Fellowships
program.
Author Information
Aleksandar D. Rakic, Karl Bertling, Yah Leng Lim,
Stephen J. Wilson, Milan Nikolic, and Thomas Taimre
School of Information Technology and Electrical Engineering
The University of Queensland
Brisbane, Australia
Dragan Indjin, Alexander Valavanis, EdmundH. Linfield, and
A. Giles Davies
University of Leeds
Leeds, UK
Graeme Walker and Blake Ferguson
Queensland Institute of Medical Research
Herston, Australia
Tarl W. Prow, Helmut Schaider, and H. Peter Soyer
Translational Research Institute
Brisbane, Australia
References
1. C. Yu, S. Fan, Y. Sun, and E. Pickwell-MacPherson, The potential of terahertz imag-
ing for cancer diagnosis: A review of investigations to date, Quant. Imag. Med. Surg. 2
(1), pp. 33–45, 2012.
Continued on next page
10.1117/2.1201409.005613 Page 3/3
2. G. Giuliani, M. Norgia, S. Donati, and T. Bosch, Laser diode self-mixing technique
for sensing applications, J. Opt. A, Pure Appl. Opt. 4 (6), pp. S283–S294, 2002.
3. P. Dean, Y. L. Lim, A. Valavanis, R. Kliese, M. Nikolic´, P. Suraj Khanna, M.
Lachab, et al., Terahertz imaging through self-mixing in a quantum cascade laser, Opt.
Lett. 36 (13), pp. 2587–2589, 2011.
4. A. D. Rakic´, D. Aleksandar, T. Taimre, K. Bertling, Y. L. Lim, P. Dean, D. Indjin,
et al., Swept-frequency feedback interferometry using terahertz frequency QCLs: a method
for imaging and materials analysis, Opt. Express 21 (19), pp. 22194–22205, 2013.
5. T. Taimre, K. Bertling, Y. L. Lim, P. Dean, D. Indjin, and A. D. Rakic´, Method-
ology for materials analysis using swept-frequency feedback interferometry with terahertz
frequency quantum cascade lasers, Opt. Express 22 (15), pp. 18633–18647, 2014.
6. E. M. Wurm, L.L. Lin, B. Ferguson, D. Lambie, T. W. Prow, G. J. Walker,
and H. P. Soyer, A blueprint for staging of murine melanocytic lesions based on the
Cdk4(R24C/R24C)::Tyr-NRAS(Q)(61K) model, Exp. Dermatol. 21 (9), pp. 676–681,
2012.
7. E. Chai, B. Ferguson, T. Prow, P. Soyer, and G. Walker, Three-dimensional mod-
elling for estimation of nevus count and probability of nevus-melanoma progression in a
murine model, Pigm. Cell Mel. Res. 27 (2), pp. 317–319, 2014.
c 2014 SPIE
